CROSBY Research – Pentamaster International (1665 HK/BUY): Steady 3Q23 revenue growth driven by medical devices segment; demand for automotive segment may slowdown in 4Q23

CROSBY Research – Pentamaster International (1665 HK/BUY): Steady 3Q23 revenue growth driven by medical devices segment; demand for automotive segment may slowdown in 4Q23

09 Nov 2023 Pentamaster’s 3Q23 revenue increased 16.1% YoY from MYR155.6m in 3Q22 to MYR180.7m. Automated Test Equipment (ATE) segment revenue declined 3.3% YoY to MYR98.6m due to longer project lead time and revenue recognition varied quarter by quarter. Factory